Trotabresib

Item number	Size	Delivery time	Price
TGM-T36395-1mg	1 mg	7 - 10 business days*	83.00€
TGM-T36395-5mg	5 mg	7 - 10 business days*	198.00€
TGM-T36395-1mL	1 ml	7 - 10 business days*	223.00€
TGM-T36395-10mg	10 mg	7 - 10 business days*	327.00€
TGM-T36395-25mg	25 mg	7 - 10 business days*	555.00€
TGM-T36395-50mg	50 mg	7 - 10 business days*	795.00€
TGM-T36395-100mg	100 mg	7 - 10 business days*	1,070.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Trotabresib (CC-90010) is an orally active inhibitor of BET and can be used in... more

Close menu

Product information "Trotabresib"

Description: Trotabresib (CC-90010) is an orally active inhibitor of BET and can be used in studies about advanced solid tumors. Target: Epigenetic Reader Domain. Smiles: Cn1cc(-c2cc(ccc2OCC2CC2)S(C)(=O)=O)c2ccccc2c1=O. References: CELGENE QUANTICEL RESEARCH, INC. PROCESS FOR THE PREPARATIO NOFBROMODO MAININHIBI TOR. Patent. WO2020023438.

Keywords:	CC-90010
Supplier:	TargetMol
Supplier-Nr:	T36395

Properties

Application:	Targets bromodomain-containing protein 2 (BRD2)
MW:	383.46 D
Formula:	C21H21NO4S

Database Information

CAS :	1706738-98-8\| Matching products
KEGG ID :	K08871 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Trotabresib"

Write a review